Nexentis Technologies Inc. (NXTS) stock
NXTSNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.75−0.07 (-3.98%)
Close on Nov 18, 2026Market cap $2.54MP/E –Yield –
Nexentis Technologies revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Nexentis Technologies's revenue for the twelve months ending Sep 30, 2025 was $209.00K, up 19.2% year over year. For fiscal 2024 it was $210.00K, down 20.2% from the year before. The highest annual figure on record is $438.14K in fiscal 2021.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $210.00K | -20.2% |
| FY2023 | Dec 31, 2023 | $263.00K | -33.2% |
| FY2022 | Dec 31, 2022 | $394.00K | -10.1% |
| FY2021 | Dec 31, 2021 | $438.14K | +88.6% |
| FY2020 | Dec 31, 2020 | $232.27K | +32.1% |
| FY2019 | Dec 31, 2019 | $175.82K | -58.8% |
| FY2018 | Dec 31, 2018 | $426.59K | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2025 | Sep 30, 2025 | $2.00K | -77.8% |
| Q2 FY2025 | Jun 30, 2025 | $0 | -100.0% |
| Q1 FY2025 | Mar 31, 2025 | $66.00K | +50.0% |
| Q4 FY2024 | Dec 31, 2024 | $141.00K | +33.8% |
| Q3 FY2024 | Sep 30, 2024 | $9.00K | – |
| Q2 FY2024 | Jun 30, 2024 | $17.00K | -53.6% |
| Q1 FY2024 | Mar 31, 2024 | $44.00K | -63.6% |
| Q4 FY2023 | Dec 31, 2023 | $105.38K | -53.0% |
| Q3 FY2023 | Sep 30, 2023 | $0 | -100.0% |
| Q2 FY2023 | Jun 30, 2023 | $36.61K | +17.8% |
| Q1 FY2023 | Mar 31, 2023 | $121.01K | +38.1% |
| Q4 FY2022 | Dec 31, 2022 | $224.06K | +18.4% |
| Q3 FY2022 | Sep 30, 2022 | $51.23K | -28.2% |
| Q2 FY2022 | Jun 30, 2022 | $31.08K | -42.9% |
| Q1 FY2022 | Mar 31, 2022 | $87.63K | -28.8% |
| Q4 FY2021 | Dec 31, 2021 | $189.30K | +12.2% |
| Q3 FY2021 | Sep 30, 2021 | $71.36K | – |
| Q2 FY2021 | Jun 30, 2021 | $54.40K | – |
| Q1 FY2021 | Mar 31, 2021 | $123.07K | +93.6% |
| Q4 FY2020 | Dec 31, 2020 | $168.71K | +266.0% |
| Q3 FY2020 | Sep 30, 2020 | $0 | – |
| Q2 FY2020 | Jun 30, 2020 | $0 | – |
| Q1 FY2020 | Mar 31, 2020 | $63.57K | -51.0% |
| Q4 FY2019 | Dec 31, 2019 | $46.09K | – |
| Q3 FY2019 | Sep 30, 2019 | $0 | – |
| Q2 FY2019 | Jun 30, 2019 | $0 | – |
| Q1 FY2019 | Mar 31, 2019 | $129.73K | – |
See a number that looks wrong?